Advanced metabolic and weight loss support.
Tirzepatide is a dual GIP and GLP-1 receptor agonist — the next generation of metabolic support peptides. By targeting two complementary hormone pathways simultaneously, Tirzepatide delivers more powerful appetite suppression and metabolic improvement than single-pathway approaches. Clinical trials have demonstrated superior weight loss outcomes compared to other GLP-1 medications, making it the most advanced peptide option for clients with significant weight loss goals or metabolic health challenges.
Tirzepatide protocols are highly individualised and guided by our wellness team from start to finish. Dose titration is carefully managed to maximise results while minimising side effects. Most clients see significant changes in appetite and body composition within 4–8 weeks, with optimal results typically achieved over a 12–24 week programme. Regular check-ins keep your plan on track.
All peptide protocols at REGEN105 are supervised by our wellness team and tailored to your individual health profile, goals, and current medications.
Schedule a consultation with our team to learn how Tirzepatide can support your wellness journey.
All peptide recommendations are guided by our wellness team. Individual results may vary.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. These statements have not been evaluated by the Food and Drug Administration.